NCT01870570

Brief Summary

The purpose of this study is to determine and compare the glycaemic index values and response parameters of 6 food products between 3 laboratories.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2013

Shorter than P25 for not_applicable

Geographic Reach
3 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

June 3, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 6, 2013

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

August 21, 2014

Status Verified

August 1, 2014

Enrollment Period

5 months

First QC Date

June 3, 2013

Last Update Submit

August 20, 2014

Conditions

Keywords

GlycaemiaInsulinemia

Outcome Measures

Primary Outcomes (1)

  • Determine and Perform Inter-Laboratory Comparison of Glycaemic Index Values of 6 Food Products

    0-120 minutes

Secondary Outcomes (9)

  • Determine and Perform Inter-Laboratory Comparison of Incremental Area Under the Curve (iAUC) of Glycaemia for Each of the 6 Food Products

    0-120 minutes

  • Determine and Perform Inter-Laboratory Comparison of the Glucose Cmax for Each of the 6 Food Products

    0-120 minutes

  • Determine and Perform Inter-Laboratory Comparison of the Blood Glucose Delta Peak for Each of the 6 Food Products

    0-120 minutes

  • Determine and Perform Inter-Laboratory Comparison of Insulinemic Index for Each of the 6 Food Products

    0-120 minutes

  • Determine and Perform Inter-Laboratory Comparison of the Incremental Area Under the Curve (iAUC) of Insulinemia for Each of the 6 Food Products

    01-20 minutes

  • +4 more secondary outcomes

Study Arms (7)

Reference Glucose

OTHER

Glucose Standard (50g of Glucose)

Other: Reference Glucose

Food Product A: Corn Flakes

EXPERIMENTAL

Corn Flakes

Other: Food Product A: Corn Flakes

Food Product B: Ginger Bread

EXPERIMENTAL

Ginger Bread

Other: Food Product B: Ginger Bread

Food Product C:Sandwiched Breakfast Biscuit

EXPERIMENTAL

Sandwiched Breakfast Biscuit

Other: Food Product C:Sandwiched Breakfast Biscuit

Food Product D: Crackers Nature

EXPERIMENTAL

Crackers Nature

Other: Food Product D: Crackers Nature

Food Product E: Breakfast Biscuit

EXPERIMENTAL

Breakfast Biscuit

Other: Food Product E: Breakfast Biscuit

Food Product F: White Bread

EXPERIMENTAL

White Bread

Other: Food Product F: White Bread

Interventions

Also known as: Glucose Standard (50g of Glucose)
Reference Glucose
Also known as: Corn Flakes
Food Product A: Corn Flakes
Also known as: Ginger Bread
Food Product B: Ginger Bread
Also known as: Sandwiched Breakfast Biscuit
Food Product C:Sandwiched Breakfast Biscuit
Also known as: Crackers Nature
Food Product D: Crackers Nature
Also known as: Breakfast Biscuit
Food Product E: Breakfast Biscuit
Also known as: White Bread
Food Product F: White Bread

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Aged 18-35 years inclusive.
  • Non-smoker.
  • BMI 19.0-25.0 kg/m2 inclusive.
  • Healthy subjects with:
  • Fasting plasma glucose \< 5,6 mM (ADA criteria,2011)
  • Insulin resistance index based on homeostasis model assessment (HOMA-IR) \<1.70
  • Fasting lipids: triglyceride \<1.70mmol/L, LDL-cholesterol\<5.00 mmol/L and HDL-cholesterol \>1.03mmol/L for males or \>1.29mmol/L for females (IDF criteria for metabolic syndrome, 2006)
  • Gamma-GT, AST and ALT \<1.5 times the upper limit of normal (ULN)
  • Complete blood count: Normal full blood count according to the investigator
  • Systolic blood pressure \<130 mmHg
  • Diastolic blood pressure \<85 mmHg
  • Resting heart rate 50-90 beats per minutes (after 3 minutes rest).
  • Stable dietary habits; normal eating patterns; no history of eating disorders or strict dieting.
  • Moderate level of physical activity (from basic daily activity to a high level of physical activity (regular physical activity at least 3 times per week))
  • Able to fast for at least 10 hours the night before each test session.
  • +4 more criteria

You may not qualify if:

  • Following a restrictive or specific diet.
  • Suffering from any inflammatory or metabolic diseases
  • Suffering from mental illness.
  • Suffering from any food allergies or hypersensitivities (wheat, milk, egg, nuts, etc).
  • Female who is pregnant (positive test results), lactating, planning pregnancy or not using acceptable contraceptive.
  • Subject having taken part in another clinical trial within the last week.
  • Subject in a situation which in the investigator's opinion could interfere with optimal participation in the present study or could constitute a special risk for the subject.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Human Nutrition Unit, The University of Sydney

Sydney, 2006, Australia

Location

Glycemic Index Laboratories

Toronto, Ontario, M5C 2N8, Canada

Location

Biofortis

Saint-Herblain, France

Location

MeSH Terms

Interventions

Glucose

Intervention Hierarchy (Ancestors)

HexosesMonosaccharidesSugarsCarbohydrates

Study Officials

  • David Gendre, Dr.

    BioFortis

    PRINCIPAL INVESTIGATOR
  • Thomas Wolever, Dr.

    Glycemic Index Laboratories, Inc

    PRINCIPAL INVESTIGATOR
  • Jennie Brand Miller, Dr.

    University of Sydney

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 3, 2013

First Posted

June 6, 2013

Study Start

June 1, 2013

Primary Completion

November 1, 2013

Study Completion

December 1, 2013

Last Updated

August 21, 2014

Record last verified: 2014-08

Locations